Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease

Microbiome

Volumn 5, Issue 1, 2017, Pages

  Khanna, Sahil ^a   Vazquez Baeza, Yoshiki ^b   González, Antonio ^c   Weiss, Sophie ^d   Schmidt, Bradley ^a   Muñiz Pedrogo, David A ^a   Rainey, John F ^a   Kammer, Patricia ^a   Nelson, Heidi ^a   Sadowsky, Michael ^e   Khoruts, Alexander ^e   Farrugia, Stefan L ^a   Knight, Rob ^b,c   Pardi, Darrell S ^a   Kashyap, Purna C ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d University of Colorado at Boulder   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Clostridium difficile infection; Fecal microbiota transplantation; Inflammatory bowel disease; Microbiome

Indexed keywords

FIDAXOMICIN; METRONIDAZOLE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DYSBIOSIS; ENGRAFTMENT; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY BOWEL DISEASE; MALE; MICROBIAL DIVERSITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; TREATMENT RESPONSE; BACTERIUM; CLASSIFICATION; CLOSTRIDIUM INFECTIONS; COMPLICATION; DNA SEQUENCE; FECES; GENETICS; INTESTINE FLORA; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 85029744525     PISSN: None     EISSN: 20492618     Source Type: Journal    
DOI: 10.1186/S40168-017-0269-3     Document Type: Article

References (28)

1. Khanna S, Tosh PK. A clinician's primer on the role of the microbiome in human health and disease. Mayo Clin Proc. 2014;89(1):107-14.
2. Khanna S, Pardi DS. Clinical implications of antibiotic impact on gastrointestinal microbiota and Clostridium difficile infection. Expert Rev Gastroenterol Hepatol. 2016;1-8. [Epub ahead of print].
3. Lessa FC, Winston LG, McDonald LC, Emerging Infections Program CdST. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(24):2369-70.
4. Orenstein R, Dubberke E, Hardi R, Ray A, Mullane K, Pardi DS, Ramesh MS, Investigators PC. Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD study. Clin Infect Dis. 2016;62(5):596-602.
5. Khanna S, Pardi DS, Kelly CR, Kraft CS, Dhere T, Henn MR, Lombardo MJ, Vulic M, Ohsumi T, Winkler J et al. A novel microbiome therapeutic increases gut microbial diversity and prevents recurrent Clostridium difficile infection. J Infect Dis. 2016.
6. Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology. 2015;149(1):223-37.
7. Khoruts A, Rank KM, Newman KM, Viskocil K, Vaughn BP, Hamilton MJ, Sadowsky MJ. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2016;14(10):1433-8.
8. Khanna S, Weatherly R, Kammer PP, Pardi DS. Management and outcomes of patients with failed fecal microbiota transplantation for recurrent Clostridium difficile infection. Am J Gastroenterol. 2015;110:S580.
9. Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149(1):102-9. e106.
10. Rossen NG, Fuentes S, van der Spek MJ, Tijssen JG, Hartman JH, Duflou A, Lowenberg M, van den Brink GR, Mathus-Vliegen EM, de Vos WM, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149(1):110-8. e114.
11. Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, Leong RW, Connor S, Ng W, Paramsothy R et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389(10075):1218-1228.
12. Khanna S, Pardi DS. Clostridium difficile infection: management strategies for a difficult disease. Ther Adv Gastroenterol. 2014;7(2):72-86.
13. Tariq R, Weatherly R, Kammer P, Pardi DS, Khanna S. Donor screening experience for fecal microbiota transplantation in patients with recurrent C. difficile infection. J Clin Gastroenterol. 2016.
14. Kopylova E, Noe L, Touzet H. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics. 2012;28(24):3211-7.
15. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, Andersen GL, Knight R, Hugenholtz P. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6(3):610-8.
16. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335-6.
17. Faith DP, Baker AM. Phylogenetic diversity (PD) and biodiversity conservation: some bioinformatics challenges. Evol Bioinform Online. 2006;2:121-8.
18. Mandal S, Van Treuren W, White RA, Eggesbo M, Knight R, Peddada SD. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb Ecol Health Dis. 2015;26:27663.
19. Weingarden A, Gonzalez A, Vazquez-Baeza Y, Weiss S, Humphry G, Berg-Lyons D, Knights D, Unno T, Bobr A, Kang J, et al. Dynamic changes in short-and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome. 2015;3:10.
20. Halfvarson J, Brislawn CJ, Lamendella R, Vazquez-Baeza Y, Walters WA, Bramer LM, D'Amato M, Bonfiglio F, McDonald D, Gonzalez A, et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol. 2017;2:17004.
21. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005;71(12):8228-35.
22. Vazquez-Baeza Y, Pirrung M, Gonzalez A, Knight R. EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience. 2013;2(1):16.
23. Knights D, Kuczynski J, Charlson ES, Zaneveld J, Mozer MC, Collman RG, Bushman FD, Knight R, Kelley ST. Bayesian community-wide cultureindependent microbial source tracking. Nat Methods. 2011;8(9):761-3.
24. Jones E, Oliphant E, Peterson P, et al. SciPy: open source scientific tools for Python, 2001-, http://www.scipy.org/[Online; Accessed 2017-04-06].
25. Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15(3):382-92.
26. Faith DP. Phylogenetic diversity, functional trait diversity and extinction: avoiding tipping points and worst-case losses. Philos Trans R Soc Lond B Biol Sci. 2015;370(1662):20140011.
27. Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, Bakow B, Curran P, McKenney J, Tisch A, et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent clostridium difficile infection: a randomized trial. Ann Intern Med. 2016;165(9):609-16.
28. Staley C, Kelly CR, Brandt LJ, Khoruts A, Sadowsky MJ. Complete microbiota engraftment is not essential for recovery from recurrent Clostridium difficile infection following fecal microbiota transplantation. mBio 2016;7(6).